Tina K. Garyantes

Person

Warren, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Enantiomerically purified GPER agonist for use in treating disease...
- Patent number 11,760,749
- Issue date Sep 19, 2023
- LINNAEUS THERAPEUTICS, INC.
- Christopher Natale
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Enantiomerically purified GPER agonist for use in treating disease...
- Patent number 10,934,277
- Issue date Mar 2, 2021
- LINNAEUS THERAPEUTICS, INC.
- Christopher Natale
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sodium channel modulators for the treatment of pain and diabetes
- Patent number 9,458,118
- Issue date Oct 4, 2016
- Chromocell Corporation
- Olga Babich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Electrical field stimulation of eukaryotic cells
- Patent number 7,276,206
- Issue date Oct 2, 2007
- Merck & Co., Inc.
- Paul R. Augustine
- G01 - MEASURING TESTING
Information Patent Grant
Virtual wells for use in high throughput screening assays
- Patent number 6,565,813
- Issue date May 20, 2003
- Merck & Co., Inc.
- Tina Garyantes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method and apparatus for wash, resuspension, recollection and local...
- Patent number 5,888,835
- Issue date Mar 30, 1999
- Chiron Diagnostics Corporation
- Steven E. Bushnell
- G01 - MEASURING TESTING

Patents Applicationslast 30 patents

Information Patent Application
ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE...
- Publication number 20250171421
- Publication date May 29, 2025
- Linnaeus Therapeutics, Inc.
- Christopher NATALE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ONCOLOGIC VARIATIONS ASSOCIATED WITH CANCER AND METHODS OF TREATMENT
- Publication number 20240376547
- Publication date Nov 14, 2024
- Linnaeus Therapeutics, Inc.
- Tina GARYANTES
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DIAGNOSTIC METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER
- Publication number 20240245674
- Publication date Jul 25, 2024
- Linnaeus Therapeutics, Inc.
- Christopher NATALE
- G01 - MEASURING TESTING
Information Patent Application
ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE...
- Publication number 20230382896
- Publication date Nov 30, 2023
- Linnaeus Therapeutics, Inc.
- Christopher NATALE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE...
- Publication number 20220089576
- Publication date Mar 24, 2022
- Linnaeus Therapeutics, Inc.
- Christopher NATALE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE...
- Publication number 20220033385
- Publication date Feb 3, 2022
- Linnaeus Therapeutics, Inc.
- Christopher NATALE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE...
- Publication number 20200140417
- Publication date May 7, 2020
- Linnaeus Therapeutics, Inc.
- Christopher NATALE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENANTIOMERICALLY PURIFIED GPER ANGONIST FOR USE IN TREATING DISEASE...
- Publication number 20200024262
- Publication date Jan 23, 2020
- Linnaeus Therapeutics, Inc.
- Christopher NATALE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE NaV1.7 INHIBITORS FOR THE TREATMENT OF DIABETES
- Publication number 20170304306
- Publication date Oct 26, 2017
- CHROMOCELL CORPORATION
- Yanlin WANG-FISCHER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SODIUM CHANNEL MODULATORS FOR THE TREATMENT OF PAIN AND DIABETES
- Publication number 20160221974
- Publication date Aug 4, 2016
- CHROMOCELL CORPORATION
- Olga BABICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SODIUM CHANNEL MODULATORS FOR THE TREATMENT OF PAIN AND DIABETES
- Publication number 20160130239
- Publication date May 12, 2016
- CHROMOCELL CORPORATION
- Olga BABICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND MATERIALS USING SIGNALING PROBES
- Publication number 20160123959
- Publication date May 5, 2016
- CHROMOCELL CORPORATION
- Kambiz Shekdar
- G01 - MEASURING TESTING
Information Patent Application
METHODS AND MATERIALS USING SIGNALING PROBES
- Publication number 20130323726
- Publication date Dec 5, 2013
- CHROMOCELL CORPORATION
- Kambiz Shekdar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DNA FRAGMENTATION ASSAY
- Publication number 20100248224
- Publication date Sep 30, 2010
- Sanofi-Aventis
- Tina Garyantes
- G01 - MEASURING TESTING
Information Patent Application
Electrical field stimulation of eukaryotic cells
- Publication number 20050164161
- Publication date Jul 28, 2005
- Paul R. Augustine
- G01 - MEASURING TESTING
Information Patent Application
Virtual wells for use in high throughput screening assays
- Publication number 20040018615
- Publication date Jan 29, 2004
- Tina K. Garyantes
- C40 - COMBINATORIAL CHEMISTRY

Tina K. Garyantes

Person

Patents Grantslast 30 patents

Enantiomerically purified GPER agonist for use in treating disease...

Enantiomerically purified GPER agonist for use in treating disease...

Sodium channel modulators for the treatment of pain and diabetes

Electrical field stimulation of eukaryotic cells

Virtual wells for use in high throughput screening assays

Method and apparatus for wash, resuspension, recollection and local...

Patents Applicationslast 30 patents

ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE...

ONCOLOGIC VARIATIONS ASSOCIATED WITH CANCER AND METHODS OF TREATMENT

DIAGNOSTIC METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER

ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE...

ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE...

ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE...

ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE...

ENANTIOMERICALLY PURIFIED GPER ANGONIST FOR USE IN TREATING DISEASE...

SELECTIVE NaV1.7 INHIBITORS FOR THE TREATMENT OF DIABETES

SODIUM CHANNEL MODULATORS FOR THE TREATMENT OF PAIN AND DIABETES

SODIUM CHANNEL MODULATORS FOR THE TREATMENT OF PAIN AND DIABETES

METHODS AND MATERIALS USING SIGNALING PROBES

METHODS AND MATERIALS USING SIGNALING PROBES

DNA FRAGMENTATION ASSAY

Electrical field stimulation of eukaryotic cells

Virtual wells for use in high throughput screening assays